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1. INTRODUCTION {#jmv25686-sec-0010}
===============

Respiratory viral infection causes widespread hospitalization rates and mortality rates in children and especially causes more deaths worldwide in children less than 5 years.[^1^](#jmv25686-bib-0001){ref-type="ref"}, [^2^](#jmv25686-bib-0002){ref-type="ref"} The common respiratory virus are respiratory syncytial virus (RSV), human rhinovirus (HRV), human parainfluenza virus (PIV), influenza A virus (FluA), influenza B virus (FluB), adenovirus (ADV), human coronavirus (HCoV), human metapneumovirus (HMPV), human bocavirus (HBoV), and enterovirus (EV).[^3^](#jmv25686-bib-0003){ref-type="ref"} In recent years, many mono real‐time quantitative PCR (RT‐qPCR), multiplex reverse transcription PCR and multiplex real‐time quantitative PCR (mRT‐qPCR) were widely applied in well‐equipped laboratories for detection of respiratory virus. The mono RT‐qPCR[^4^](#jmv25686-bib-0004){ref-type="ref"} has acceptable sensitivity and specificity for detection of respiratory virus, but only detects one virus per tube. The multiplex reverse transcription PCR[^1^](#jmv25686-bib-0001){ref-type="ref"} enables the detection of virus coinfection but is labor‐intensive and susceptible to cross‐contamination as it requires post PCR analysis. The mRT‐qPCR[^5^](#jmv25686-bib-0005){ref-type="ref"} has the advantages of high throughput detection and labor‐saving, however, the sensitivity is not yet adequate for assessing clinical specimens with a low viral load.

In our previous study, we successfully applied the locked nucleic acid (LNA) technology to develop the OTNRT‐PCR assay to detect RSV[^6^](#jmv25686-bib-0006){ref-type="ref"} and the mOTNRT‐PCR assay to detect RSV, HRV, and HMPV in one tube,[^7^](#jmv25686-bib-0007){ref-type="ref"} however, we only included 3 respiratory viruses. Aiming to detect more respiratory viruses and improve the sensitivity of the mRT‐qPCR, in the present study, we adopted the design of locked nucleic acid‐modified primers and developed a multiplex one‐tube nested real‐time PCR (mOTNRT‐PCR) assay panel with the advantages of higher sensitivity, easier performance, and better cost‐effectiveness.

2. MATERIALS AND METHODS {#jmv25686-sec-0020}
========================

2.1. Clinical samples {#jmv25686-sec-0030}
---------------------

A total of 468 nasopharyngeal aspirates samples were collected from inpatients presenting with acute respiratory symptoms at the Children\'s Hospital of Hebei Province (China) from June to October, 2017 and from February to June, 2018. Of those 264 (56.41%) were female and 204 (43.59%) were male. Ages ranged from 34 days to 11 years old and 453 (96.79%) were under 5 years old. Briefly, 1.8 mL of nasopharyngeal aspirate was collected in 2 mL of transport medium containing sodium glycerophosphate, sodium thioglycolate, cysteine hydrochloride, CaCl~2~, methylene blue, and agar and stored at −80°C. The study was conducted with the approval of the Ethics Committee of Children\'s Hospital of Hebei Province, and written informed consent was obtained from the children\'s parents.

2.2. Nucleic acid extraction {#jmv25686-sec-0040}
----------------------------

Total RNA/DNA was extracted from 200 µL of clinical samples using the QIAamp MinElute Virus Spin Kit (Qiagen, Hilden, Germany). The extracts were eluted in 50 µL of DNase‐free and RNase‐free diethylpyrocarbonate(DEPC)‐treated water and stored at −80°C until use.

2.3. Primers and probes design for mOTNRT‐PCR assay panel {#jmv25686-sec-0050}
---------------------------------------------------------

The mOTNRT‐PCR assay panel consisted of five separate internally controlled RT‐qPCR assays targeting 14 respiratory viruses. Assay 1, RSV, HRV, and HMPV; assay 2, PIV1, PIV2, and PIV3; assay 3, EV, FluA, and FluB; assay 4, HCoV229E, HCoVOC43 and HCoVNL63; assay 5, ADV, HBoV, and Rnasep. All the sequences of LNA‐outer primer, inner primer, and probe were obtained either from the reported literature[^4^](#jmv25686-bib-0004){ref-type="ref"}, [^8^](#jmv25686-bib-0008){ref-type="ref"}, [^9^](#jmv25686-bib-0009){ref-type="ref"}, [^10^](#jmv25686-bib-0010){ref-type="ref"}, [^11^](#jmv25686-bib-0011){ref-type="ref"}, [^12^](#jmv25686-bib-0012){ref-type="ref"}, [^13^](#jmv25686-bib-0013){ref-type="ref"}, [^14^](#jmv25686-bib-0014){ref-type="ref"}, [^15^](#jmv25686-bib-0015){ref-type="ref"}, [^16^](#jmv25686-bib-0016){ref-type="ref"}, [^17^](#jmv25686-bib-0017){ref-type="ref"}, [^18^](#jmv25686-bib-0018){ref-type="ref"}, [^19^](#jmv25686-bib-0019){ref-type="ref"}, [^20^](#jmv25686-bib-0020){ref-type="ref"}, [^21^](#jmv25686-bib-0021){ref-type="ref"}, [^22^](#jmv25686-bib-0022){ref-type="ref"} or slightly modified by removing a few bases of reported inner primers. All the outer primers were modified by LNA. BLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) was then performed to ensure the specificity of primers and probes. All the primers probes were tested using Oligo7 to minimize duplex formation and hairpin formation. The primers and probes were synthesized from Sangon Biotech (Shanghai, China). The detailed sequences of primer and probe are shown in Table [1](#jmv25686-tbl-0001){ref-type="table"}.

###### 

Primers and probes used in the multiplex closed one‐tube nested real‐time polymerase chain reaction assay panel

  Assay   Primer/Probe                                                     Sequence (5′‐3′)                               Product size, bp   Gene                                                             References
  ------- ---------------------------------------------------------------- ---------------------------------------------- ------------------ ---------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------
  1       RSV‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}        CA+CW+GAA+GA+TG+CWAAT+CATAAATTCA               374                N                                                                Kim et al[^8^](#jmv25686-bib-0008){ref-type="ref"}; Sanghavi et al[^9^](#jmv25686-bib-0009){ref-type="ref"}
          RSV‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}        CW+GA+TC+TRT+CT+CCT+GCTGCTA                                                                                                        
          RSV‐inner‐F                                                      CACWGAAGATGCWAATCATAAATTCA                     89                                                                                  
          RSV‐inner‐R                                                      GTATYTTTATRGTGTCTTCYCTTCCTAACC                                                                                                     
          RSV‐Probe                                                        FAM‐TAATAGGTATGTTATATGCKATGTC‐BHQ1                                                                                                 
          HRV‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}        HC+AA+GYA+CTTCT+GTYWCCCCSG                     397                5′UTR                                                            Wisdom et al[^10^](#jmv25686-bib-0010){ref-type="ref"}; Hammitt et al[^11^](#jmv25686-bib-0011){ref-type="ref"}
          HRV‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}        GA+AA+CAC+GGA+CA+CCCAAAGTAGT                                                                                                       
          HRV‐inner‐F                                                      TGGACAGGGTGTGAAGAGC                            144                                                                                 
          HRV‐inner‐R                                                      CAAAGTAGTCGGTCCCATCC                                                                                                               
          HRV‐Probe                                                        CY5‐TCCTCCGGCCCCTGAATG‐BHQ3                                                                                                        
          HMPV‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       CATATAAG+CA+T+G+C+TA+TATTAAAA+GAGTCTC          475                N                                                                Maertzdorf et al[^4^](#jmv25686-bib-0004){ref-type="ref"}; Dare et al[^12^](#jmv25686-bib-0012){ref-type="ref"}
          HMPV‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       GT+GAATATTAA+G+G+CA+C+CTACACATAATAARA                                                                                              
          HMPV‐inner‐F                                                     CATATAAGCATGCTATATTAAAAGAGTCTC                 163                                                                                 
          HMPV‐inner‐R                                                     CCTATTTCTGCAGCATATTTGTAATCAG                                                                                                       
          HMPV‐Probe                                                       VIC‐TGYAATGATGAGGGTGTCACTGCGGTTG‐BHQ1                                                                                              
  2       PIV1‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       A+GGA+TGT+G+CA+GATATAGGGAA                     195                HN                                                               Perrott et al[^13^](#jmv25686-bib-0013){ref-type="ref"}
          PIV1‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       GT+CT+CA+TT+CA+CAGTGGGCAA                                                                                                          
          PIV1‐inner‐F                                                     TTTAAACCCGGTAATTTCTCATACCT                     81                                                                                  
          PIV1‐inner‐R                                                     CCCCTTGTTCCTGCAGCTATT                                                                                                              
          PIV1‐Probe                                                       FAM‐TGACATCAACGACAACAGGAAATCATGTTCTG‐BHQ1                                                                                          
          PIV2‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       AA+C AA+T+CT+G+CTG CAGCAT TT                   158                HN                                                               Sanghavi et al[^9^](#jmv25686-bib-0009){ref-type="ref"}; Bellau‐Pujol et al[^14^](#jmv25686-bib-0014){ref-type="ref"}
          PIV2‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       C+GT+GG+CA+TA+AT+CTTCTTTTT                                                                                                         
          PIV2‐inner‐F                                                     CCATTTACCTAAGTGATGGAA                          116                                                                                 
          PIV2‐inner‐R                                                     CGTGGCATAATCTTCTTTTT                                                                                                               
          PIV2‐Probe                                                       CY5‐AATCGCAAAAGCTGTTCAGTCAC‐BHQ3                                                                                                   
          PIV3‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       T+TA+CARA+TA+GG+GATAATAACTGT                   151                HN                                                               Sanghavi et al[^9^](#jmv25686-bib-0009){ref-type="ref"}; Bellau‐Pujol et al[^14^](#jmv25686-bib-0014){ref-type="ref"}
          PIV3‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       CTTT+GG+GA+GTT+GAACACAGTT                                                                                                          
          PIV3‐inner‐F                                                     TTACARATAGGGATAATAACTGT                        115                                                                                 
          PIV3‐inner‐R                                                     TTAGGAGTGCTAGAGAACAT                                                                                                               
          PIV3‐Probe                                                       VIC‐AAACTCAGACTTGGTACCTGACTTAAAT‐BHQ1                                                                                              
  3       EV‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}         HC+AA+GYA+CTTCT+GTYWCCCCSG                     402                5′UTR                                                            Wisdom et al[^10^](#jmv25686-bib-0010){ref-type="ref"}; Brittain‐Long et al[^15^](#jmv25686-bib-0015){ref-type="ref"} ^modified^
          EV‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}         GA+AA+CAC+GGA+CA+CCCAAAGTAGT                                                                                                       
          EV‐inner‐F                                                       GTGYGAAGAGTCTATTGAGCTA                         141                                                                                 
          EV‐inner‐R                                                       ACACCCAAAGTAGTCGGTT                                                                                                                
          EV‐Probe                                                         FAM‐CGGCCCCTGAATGCGGCTAATC‐BHQ1                                                                                                    
          FluA‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       TCA+AAGC+CGAGATCGCGCAG                         189                M                                                                This study
          FluA‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       G+CATT+TTG+GA+CAAAGCGTCTAC                                        Lee et al[^16^](#jmv25686-bib-0016){ref-type="ref"} ^modified^   
          FluA‐inner‐F                                                     GAATGGCTAAAGACAAGACCAAT                        118                                                                                 
          FluA‐inner‐R                                                     GCATTTTGGACAAAGCGTCTAC                                                                                                             
          FluA‐Probe                                                       CY5‐AGTCCTCGCTCACTGGGCACGGTG‐BHQ3                                                                                                  
          FluB‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       TG+CCT+CCAC+AAAAATACGG                         218                HA                                                               Perrott et al[^13^](#jmv25686-bib-0013){ref-type="ref"}
          FluB‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       C+C+TG+CAAT+CATTCCTTCCCA                                                                                                           
          FluB‐inner‐F                                                     AAATACGGTGGATTAAATAAAAGCAA                     170                                                                                 
          FluB‐inner‐R                                                     CCA GCA ATA GCT CCG AAG AAA                                                                                                        
          FluB‐Probe                                                       VIC‐CACCCATATTGGGCAATTTCCTATGGC‐BHQ1                                                                                               
  4       HCoV229E‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}   CA+GT+CAAAT+GGGCTGATGCA                        638                N                                                                Hammitt et al[^11^](#jmv25686-bib-0011){ref-type="ref"}; Li et al[^17^](#jmv25686-bib-0017){ref-type="ref"} ^modified^
          HCoV229E‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}   A+CGA+GAA+GG+CTTAGGAGTAC                                                                                                           
          HCoV229E‐inner‐F                                                 CAGTCAAATGGGCTGATGCA                           76                                                                                  
          HCoV229E‐inner‐R                                                 AAAGGGCTATAAAGAGAATAAGGTATTCT                                                                                                      
          HCoV229E‐Probe                                                   FAM‐CCCTGACGACCACGTTGTGGTTCA‐BHQ1                                                                                                  
          HCoVOC43‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}   ATT+GCA+CCA+GGAGTCCCA                          316                N                                                                Hammitt et al[^11^](#jmv25686-bib-0011){ref-type="ref"}; Li et al[^17^](#jmv25686-bib-0017){ref-type="ref"} ^modified^
          HCoVOC43‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}   TT+CC+T+GA+GC+CTT+CAATATAGTAAC                                                                                                     
          HCoVOC43‐inner‐F                                                 ATGAGGCTATTCCGACTAGG                           72                                                                                  
          HCoVOC43‐inner‐R                                                 TTCCTGAGCCTTCAATATAGTAAC                                                                                                           
          HCoVOC43‐Probe                                                   CY5‐TCCGCCTGGCACGGTACTCCCT‐BHQ3                                                                                                    
          HCoVNL63‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}   A+GATGA+GCA+GATT+GGTTATTGG                     211                N                                                                Bastein et al[^18^](#jmv25686-bib-0018){ref-type="ref"}; Esposito et al[^19^](#jmv25686-bib-0019){ref-type="ref"} ^modified^
          HCoVNL63‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}   ATTACGTTT+GC+GATTA+C+CAAGACT                                                                                                       
          HCoVNL63‐inner‐F                                                 GACCTTAAATTCAGACAACGTTCT                       96                                                                                  
          HCoVNL63‐inner‐R                                                 ATTACGTTTGCGATTACCAAGACT                                                                                                           
          HCoVNL63‐Probe                                                   VIC‐TAACAGTTTTAGCACCTTCCTTAGCAACCCAAACA‐BHQ1                                                                                       
  5       ADV‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}        TACATGCA+CATCKCSGGVCAGGA                       113                Hexo                                                             Sanghavi et al[^9^](#jmv25686-bib-0009){ref-type="ref"}; Lam et al[^20^](#jmv25686-bib-0020){ref-type="ref"} ^modified^
          ADV‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}        GT+GG+GGTTYCT+GAACTTGT                                                                                                             
          ADV‐inner‐F                                                      GCY TCG GAG TAC CTG AG                         89                                                                                  
          ADV‐inner‐R                                                      GTGGGGTTYCTGAACTTGT                                                                                                                
          ADV‐Probe                                                        FAM‐CTGGTGCAGTTCGCCCGTGCCA‐BHQ1                                                                                                    
          HBoV‐outer‐F[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       GA+C+TAA+GCAA+GAG+GAATGCTA                     214                NS1                                                              Chieochansin et al[^21^](#jmv25686-bib-0021){ref-type="ref"}; Jansen et al[^22^](#jmv25686-bib-0022){ref-type="ref"} ^modified^
          HBoV‐outer‐R[^a^](#jmv25686-tbl1-note-0003){ref-type="fn"}       TCT+GC+GAT+CT+CT+ATATT+GAAGG                                                                                                       
          HBoV‐inner‐F                                                     AAATCTCTTCTGGCTACACG                           136                                                                                 
          HBoV‐inner‐R                                                     TCTGCGATCTCTATATTGAAGG                                                                                                             
          HBoV‐Probe                                                       CY5‐ATGTTGCCGCCAGTAACTCCACC‐BHQ3                                                                                                   
          Rnasep‐F                                                         AGATTTGGACCTGCGAGCG                            65                 Rnasep                                                           Zhang et al[^5^](#jmv25686-bib-0005){ref-type="ref"}
          Rnasep‐R                                                         GAGCGGCTGTCTCCACAAGT                                                                                                               
          Rnasep‐Probe                                                     VIC‐TTCTGACCTGAAGGCTCTGCGCG‐BHQ1                                                                                                   

*Note*: modified, the internal primers from the literature were modified by removing a few bases.

Abbreviations: ADV, adenovirus; BHQ, Blackblack hole quencher; CY5, Cyanine‐5; EV, enterovirus; FAM, 6‐carboxyfluorescein; FluA, influenza A virus; FluB, influenza B virus; HRV, human rhinovirus; HBoV, human bocavirus; HCoV, human coronavirus; HMPV, human metapneumovirus; LNA, locked nucleic acid; PIV, human parainfluenza virus; RSV, respiratory syncytial virus; VIC, 2′‐chloro‐7′‐phenyl‐1,4‐dichloro‐6‐carboxyfluorescein;2′‐chloro‐7′‐phenyl‐1,4‐dichloro.

\'+\' denotes a nucleotide with LNA modification.
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2.4. Preparation of plasmid standards {#jmv25686-sec-0060}
-------------------------------------

PCR products of outer primers of mOTNRT‐PCR assay panel targeting 14 respiratory viruses were cloned respectively by TsingKe Biotech Corp (Beijing, China) and confirmed by sequencing. The recombinant plasmids were quantified using a Qubit dsDNA HS Assay Kits (Life technologies Invitrogen). For mOTNRT‐PCR assay panel, each standard plasmid was adjusted to a concentration of 10^7^ copies/µL and equally mixed in each assay. The mixed plasmids were used to prepare 10‐fold serial dilutions for sensitivity analysis.

2.5. mOTNRT‐PCR assay panel {#jmv25686-sec-0070}
---------------------------

Each assay of mOTNRT‐PCR panel was carried out in a 10 µL reaction volume using a One‐Step RT‐PCR kit (Qiagen, Hilden, Germany), containing 2 µL of extracted sample, 2 µL of the 5× buffer, 0.4 µL of the dNTP mix, 0.8 µL of the enzyme mix, 0.05 µL of RRI (Takara, Dalian, China). One microliter of 10× Primers and probes mix, and 3.75 µL of RNase‐free water. PCR amplification was performed on the CFX96 Real‐Time PCR System (Bio‐Rad) and the conditions were: 50°C for 30 minutes, a 15 minutes denaturation step at 95°C, and 10 cycles at 94°C for 30 seconds, 64°C for 40 seconds and 72°C for 40 seconds, followed by 40 cycles at 94°C for 30 seconds, 54°C for 30 seconds, and 72°C for 30 seconds, with fluorescent readings taken at the annealing phase of the last 40 cycles. Cycle threshold (*C* ~t~) values were calculated using the software at the automatic threshold setting. Positive and negative controls were included in each run. The results were defined as positive if the *C* ~t~ value was not higher than 35 for all the reactions.

2.6. Analytical sensitivity, reproducibility, and specificity of the mOTNRT‐PCR assay panel {#jmv25686-sec-0080}
-------------------------------------------------------------------------------------------

Ten‐fold dilutions of mixed recombinant plasmids ranging from 10^7^ to 10^0^ copies/µL were used to analyze the sensitivity of the mOTNRT‐PCR assay panel in five reactions. In a 10 µL reaction system, the reaction mixture was prepared to contain 5 µL of 2× Qiagen Multiplex PCR Master Mix (Qiagen), 2 µL of mixed plasmid, 1 µL of 10× Primers and probes mix, and 2 µL of RNase‐free water. PCR amplification was performed on the CFX96 Real‐Time PCR System (Bio‐Rad) and the conditions were: a 15 minutes denaturation step at 95°C, and 10 cycles at 94°C for 30 seconds, 64°C for 40 seconds and 72°C for 40 seconds, followed by 40 cycles at 94°C for 30 seconds, 54°C for 30 seconds and 72°C for 30 seconds, with fluorescent readings taken at the annealing phase of the last 40 cycles. The reproducibility of the mOTNRT‐PCR was evaluated using three concentrations of mixed recombinant plasmids (10^6^, 10^4^, and 10^2^ copies/µL). Intra‐assay reproducibility and inter‐assay reproducibility of mOTNRT‐PCR were tested using three plasmids in three replicates and in three different days within a week.The specificity was retrospectively evaluated by using archived common respiratory viruses‐positive samples previously tested by respiratory pathogen 13 detection kit (13 × kit) in our lab.[^23^](#jmv25686-bib-0023){ref-type="ref"}

2.7. Comparison of clinical performance between the mOTNRT‐PCR assay panel and the RT‐qPCR assay {#jmv25686-sec-0090}
------------------------------------------------------------------------------------------------

A total of 468 clinical samples were detected by mOTNRT‐PCR. For comparison, the previously published RT‐qPCR assays[^9^](#jmv25686-bib-0009){ref-type="ref"}, [^11^](#jmv25686-bib-0011){ref-type="ref"}, [^12^](#jmv25686-bib-0012){ref-type="ref"}, [^13^](#jmv25686-bib-0013){ref-type="ref"}, [^15^](#jmv25686-bib-0015){ref-type="ref"}, [^16^](#jmv25686-bib-0016){ref-type="ref"}, [^19^](#jmv25686-bib-0019){ref-type="ref"}, [^22^](#jmv25686-bib-0022){ref-type="ref"} were also performed in parallel. Sequencing of traditional two‐step nested PCR[^14^](#jmv25686-bib-0014){ref-type="ref"}, [^20^](#jmv25686-bib-0020){ref-type="ref"}, [^24^](#jmv25686-bib-0024){ref-type="ref"} products were performed to resolve discrepant results among the two assays.

2.8. Statistical analysis {#jmv25686-sec-0100}
-------------------------

IBM SPSS Statistics, version 21 (IBM Corporation, NY) was used to perform statistical analysis. The results were analyzed using *χ* ^*2*^ tests, and value of *P* \< 0.05 was considered statistically significant.

3. RESULTS {#jmv25686-sec-0110}
==========

3.1. Sensitivity, reproducibility, and specificity of the mOTNRT‐PCR assay panel {#jmv25686-sec-0120}
--------------------------------------------------------------------------------

The sensitivity was analyzed using 10‐fold dilutions of mixed recombinant plasmids ranging from 10^7^ to 10^0^ copies/µL, yielding 20 copies/reaction for PIV1, PIV2, and PIV3, and 2 copies/reaction for other 11 viruses type/subtype. The coefficient of variation (CV) for intra‐assay and inter‐assay ranged from 0.35% to 3.66% and 0.83% to 8.29% (Table [2](#jmv25686-tbl-0002){ref-type="table"}). A total of 407 archived positive clinical samples retrospectively detected by 13 kit[^23^](#jmv25686-bib-0023){ref-type="ref"} were used to assess the specificity of the mOTNRT‐PCR. No cross‐reaction was obtained (data not shown), indicating high specificity for the mOTNRT‐PCR panel.

###### 

The intra‐assay and inter‐assay reproducibility of the multiplex closed one‐tube nested real‐time polymerase chain reaction assay panel

             Intra‐ssay CV (%)   Inter‐ssay CV (%)                        
  ---------- ------------------- ------------------- ------ ------ ------ ------
  RSV        3.66                0.64                1.57   3.67   3.19   0.83
  HRV        0.74                1.36                0.51   1.87   1.91   2.13
  HMPV       3.39                1.33                2.01   3.45   1.91   1.20
  EV         0.35                0.62                2.18   2.93   3.75   2.05
  FluA       1.12                0.62                1.35   8.29   3.57   2.58
  FluB       2.09                1.87                1.59   5.48   2.96   2.10
  PIV1       1.61                1.03                1.12   4.26   2.09   1.05
  PIV2       1.02                1.23                1.05   1.90   2.04   1.93
  PIV3       0.79                1.07                0.99   1.46   1.55   1.55
  HCoV229E   2.49                1.13                0.91   2.06   1.97   1.12
  HCoVOC43   1.50                1.75                0.97   1.50   2.54   1.99
  HCoVNL63   3.23                1.07                1.50   2.05   1.81   1.21
  ADV        2.66                1.75                0.58   3.92   2.05   2.61
  HBoV       3.25                1.39                0.89   3.60   4.76   2.36

Abbreviations: ADV, adenovirus; CV, coefficient of variations; EV, enterovirus; FluA, influenza A virus; FluB, influenza B virus; HCoV, human coronavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; HCoV, human coronavirus; PIV, human parainfluenza virus; RSV, respiratory syncytial virus.
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3.2. Comparison of clinical performance between the mOTNRT‐PCR assay panel and the RT‐qPCR assay {#jmv25686-sec-0130}
------------------------------------------------------------------------------------------------

All of the 468 clinical samples were tested by the mOTNRT‐PCR assay panel and the RT‐qPCR assay in parallel. Totally, 427 of 468 (91.24%) specimens were positive by mOTNRT‐PCR, including 262 (55.98%), 135 (28.85%), 29 (6.20%), and 1(0.21%) samples were positive for a single virus, 2 viruses, 3 viruses, and 4 viruses, respectively. As shown in Table [3](#jmv25686-tbl-0003){ref-type="table"} and Figure [1](#jmv25686-fig-0001){ref-type="fig"}, HRV, RSV, and PIV3 were the most frequently viruses detected by mOTNRT‐PCR assay with 179 (38.25%), 97 (20.73%), and 42 (8.97%), respectively. RT‐qPCR assay detected HRV 174 (37.18%), RSV 94 (20.09%), and PIV3 38 (8.12%), respectively. HCoVNL63 was not detected by either assay. A total of 35 clinical samples were positive by the mOTNTR‐PCR assay but negative by the RT‐qPCR assay using the cutoff of the RT‐qPCR assay with Ct \> 40. Sequencing of traditional two‐step nested PCR[^14^](#jmv25686-bib-0014){ref-type="ref"}, [^20^](#jmv25686-bib-0020){ref-type="ref"}, [^24^](#jmv25686-bib-0024){ref-type="ref"} products confirmed that 35 samples were true positives. The comparison of percentages of detection of specimens with *C* ~t~ ≤ 40 between the mOTNRT‐PCR and mono RT‐qPCR for a total of 468 clinical samples is displayed in Figure [1](#jmv25686-fig-0001){ref-type="fig"}. A total of 69 clinical samples detected by mOTNRT‐PCR assay were missed by RT‐qPCR using the positivity cutoff (Ct = 35) of the RT‐qPCR assay. Among them, 34 samples had a CT range of 35 to 40 detected by RT‐qPCR assay. The sensitivities of detection of the different viruses were 100%, and the specificities were more than 98% between the mOTNTR‐PCR assay and the RT‐qPCR assay. Concordance between the two assays for all viruses was more than 98%, and the kappa correlation ranged from 0.66 to 0.98.

###### 

Clinical performance of the multiplex closed one‐tube nested real‐time polymerase chain reaction panel compared with the real‐time quantitative polymerase chain reaction

  Virus      No. of samples   *C* ~t~ value   Clinical performance of the mOTNRT‐PCR compared with the RT‐qPCR                         
  ---------- ---------------- --------------- ------------------------------------------------------------------ ----- ------- ------- ------
  RSV        97/468           94/468          12.37‐35.00 vs 18.03‐39.56                                         100   99.20   99.36   0.98
  HRV        179/468          174/468         7.58‐33.43 vs 21.01‐39.66                                          100   98.30   98.93   0.98
  HMPV       36/468           34/468          10.79‐34.85 vs 18.62‐38.84                                         100   99.54   99.57   0.97
  EV         18/468           15/468          13.06‐32.13 vs 19.20‐37.65                                         100   99.33   99.36   0.91
  FluA       34/468           32/468          10.01‐29.53 vs 19.65‐37.39                                         100   99.54   99.57   0.97
  FluB       15/468           13/468          13.14‐34.15 vs 21.21‐39.18                                         100   99.56   99.57   0.93
  PIV1       23/468           21/468          8.38‐34.99 vs 18.31‐39.69                                          100   99.55   99.57   0.95
  PIV2       6/468            3/468           20.06‐31.63 vs 36.14‐39.89                                         100   99.35   99.35   0.66
  PIV3       42/468           38/468          12.77‐31.03 vs 24.00 −39.61                                        100   99.07   99.14   0.95
  HCoV229E   5/468            3/468           19.98‐25.69 vs 28.65‐34.98                                         100   99.57   99.57   0.75
  HCoVOC43   10/468           9/468           10.37‐28.94 vs 19.04‐36.62                                         100   99.78   99.79   0.95
  HCoVNL63   0/468            0/468           NA                                                                 NA    100     100     NA
  ADV        35/468           31/468          13.66‐34.52 vs 22.90‐38.63                                         100   99.08   99.15   0.93
  HBoV       18/468           16/468          9.40‐35.00 vs 16.02‐39.01                                          100   99.56   99.57   0.94

Abbreviations: ADV, adenovirus; CV, coefficient of variations; FluA, influenza A virus; FluB, influenza B virus; HBoV, human bocavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; HCoV, human coronavirus; mOTNRT‐PCR, multiplex closed one‐tube nested real‐time polymerase chain reaction; PIV, human parainfluenza virus; RSV, respiratory syncytial virus; RT‐qPCR, real‐time quantitative polymerase chain reaction.

John Wiley & Sons, Ltd.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

![The percentages of detection of specimens with *C* ~t~ ≤ 40 analyzed by mOTNRT‐PCR panel (M) and mono RT‐qPCR (S) for a total of 468 clinical samples. A total of 34 samples had a *C* ~t~ range of 35 to 40 detected by RT‐qPCR assay. mOTNRT‐PCR, multiplex closed one‐tube nested real‐time polymerase chain reaction; RT‐qPCR, real‐time quantitative polymerase chain reaction](JMV-9999-na-g001){#jmv25686-fig-0001}

4. DISCUSSION {#jmv25686-sec-0140}
=============

LNA has been reported to modify primers and probes in many studies, thus increasing the maximum annealing temperature of primers/probes and improving amplification sensitivity and specificity.[^25^](#jmv25686-bib-0025){ref-type="ref"}, [^26^](#jmv25686-bib-0026){ref-type="ref"} In the present study, LNA‐modified outer primers (without changing the sequences) were used to develop an mOTNRT‐PCR assay panel for simultaneous detection of 14 respiratory viruses in five reactions. The purpose of this design was to maximize the difference in the annealing temperatures (64°C vs 54°C) between the outer primer modified by LNA and inner primer sets, allowing one‐step nested amplification successfully to be carried out via temperature switch PCR (TSP).[^27^](#jmv25686-bib-0027){ref-type="ref"}, [^28^](#jmv25686-bib-0028){ref-type="ref"} To our best knowledge, this is the first report on the simultaneous detection of 14 respiratory viruses in five closed one‐tube reactions using LNA.

For the mOTNRT‐PCR assay panel, the working concentration of LNA‐modified outer primers, inner primers, and probes in each reaction was carefully optimized, enabling minimize the competition between the outer primers and inner primers, as well as primers and probes of targeted viruses in each reaction. The reaction parameters and the running conditions of the mOTNRT‐PCR assay were also optimized, allowing the five reactions to perform simultaneously. This study demonstrated that mOTNRT‐PCR assay panel revealed high sensitivity range from 2 to 20 copies/reaction of 14 respiratory viruses using 10‐fold dilutions of mixed recombinant plasmids, high specificity, and reliable reproducibility (Table [3](#jmv25686-tbl-0003){ref-type="table"}).

The mOTNRT‐PCR assay panel was further evaluated and compared with the RT‐qPCR assay using 468 clinical samples. As shown in Table [3](#jmv25686-tbl-0003){ref-type="table"} and Figure [1](#jmv25686-fig-0001){ref-type="fig"}, HRV, RSV, and PIV3 were the most commonly found respiratory viruses by the two assays which is consistent with the previous report.[^17^](#jmv25686-bib-0017){ref-type="ref"} The reported RT‐qPCR thresholds typically ranged from 35 to 40. A total of 69 clinical samples detected by the mOTNRT‐PCR assay were missed by RT‐qPCR using the positivity cutoff of the RT‐qPCR assay set at a *C* ~t~ of 35. When a *C* ~t~ cutoff of 40 for RT‐qPCR was used, 35 samples were deemed to be positive by mOTNRT‐PCR assay but negative by RT‐qPCR (Table [3](#jmv25686-tbl-0003){ref-type="table"} and Figure [1](#jmv25686-fig-0001){ref-type="fig"}). Moreover, the range of *C* ~t~ values of the mOTNRT‐PCR assay (7.58‐35.00) was smaller than the RT‐qPCR (16.02‐39.89) in those positive samples using both assays (Table [3](#jmv25686-tbl-0003){ref-type="table"}), suggesting that the mOTNRT‐PCR assay is more sensitive than the reported RT‐qPCR assay in detecting clinical specimens. Besides, the mOTNRT‐PCR can detect 14 common respiratory viruses in five reactions in 2.7 hours and cost \$7.5 (excluding nucleic acid extraction) for one sample. Compared with the mono RT‐qPCR assay for detecting one virus per tube, the mOTNRT‐PCR has the advantages of being highly sensitive, easy to operate, rapid, and cost‐effective. In addition, the human RNasep gene as an internal control can validate the RNA extraction procedure and prevent errors in the process of sampling and RT‐PCR.

As to the mixed infections, 165 of 468 (35.26%) specimens were detected by the mOTNRT‐PCR, including 135 of 468 (28.85%), 29 of 468 (6.20%) and 1 of 468 (0.21%) samples involved in 2 viruses, 3 viruses, and 4 viruses, respectively. Virus coinfections were more frequently detected in children less than 5 years old (32.05%, 150/468) compared with the older children (3.21%; 15/468; *P* \< 0.05). For children less than 5 years, RSV and HRV (7.05%, 33/468) were the most commonly found in co‐infections, which is similar to the previous report.[^29^](#jmv25686-bib-0029){ref-type="ref"}

The mOTNRT‐PCR assay panel has limitations. First, it requires five parallel assays with only moderate throughput in each assay. Second, we only evaluate the clinical specimens from children and the clinical data is incomplete. Future research will attempt to develop a mOTNRT‐PCR assay to detect as many viruses as possible in one assay, evaluate a large number of samples from different populations and integrate clinical information for more comprehensive analysis.

In summary, the mOTNRT‐PCR assay developed in this study using LNA is a sensitive, labor‐saving, and cost‐effectiveness method for detecting 14 respiratory viruses in five reactions. It may have great potential for routine surveillance of respiratory virus infection in China.
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